Q: Why is CKD staged by albuminuria as well as eGFR?

Because albuminuria independently predicts progression and cardiovascular risk at any given eGFR. KDIGO classifies CKD by Cause, GFR category (G1–G5), AND albuminuria category (A1 300 mg/g by urine albumin-to-creatinine ratio), displayed as a color-coded risk heat map. Two patients with the same eGFR but different albuminuria can sit in very different risk zones, so a urine ACR should be checked alongside eGFR — staging on eGFR alone is incomplete.

Question 1

What is the difference between eGFR and creatinine clearance (CrCl)?

Accepted Answer

eGFR (CKD-EPI) estimates glomerular filtration rate normalized to a standard 1.73 m² body surface area and does not use body weight; it is the marker used to diagnose and stage CKD. Cockcroft-Gault creatinine clearance (CrCl) is reported in mL/min, includes body weight, and is the value drug labels — especially the direct oral anticoagulants — use for renal dose adjustment. They are not interchangeable: eGFR for kidney-disease staging, CrCl for label-based drug dosing.

Question 2

What does removing race from the 2021 CKD-EPI equation mean?

Accepted Answer

The 2009 CKD-EPI equation applied a multiplier (about 1.16) for patients identified as Black, which raised their reported eGFR and could delay recognition of CKD, referral, and transplant listing. The 2021 refit (Inker et al., NEJM 2021) removed the race term entirely, giving one equation for all adults. The NKF–ASN Task Force recommended US labs adopt it immediately, and the KDIGO 2024 guideline endorses it. This calculator uses the 2021 race-free equation by default; the 2009 race-adjusted version is shown for reference only.

Question 3

How low does eGFR have to be before seeing a nephrologist?

Accepted Answer

KDIGO 2024 recommends nephrology referral for eGFR below 30 mL/min/1.73 m² (stage G4–G5), severe albuminuria (ACR ≥300 mg/g, category A3), a sustained or rapidly progressive fall in GFR, or a 5-year kidney-failure risk of 3–5% on a validated risk tool. Refractory hypertension, persistent electrolyte abnormalities, and suspected hereditary or glomerular disease are also referral triggers. An eGFR below 15 (G5) defines kidney failure and prompts dialysis or transplant evaluation.

Question 4

Can a single low eGFR diagnose chronic kidney disease?

Accepted Answer

No. CKD is defined as reduced eGFR (<60) or markers of kidney damage such as albuminuria present for MORE THAN 3 months. A single low eGFR may reflect acute kidney injury, dehydration, or a transient change rather than chronic disease, so chronicity must be established with repeat testing or prior values. After an episode of AKI, KDIGO suggests deferring a CKD diagnosis until at least 3 months have passed.

Question 5

Why is CKD staged by albuminuria as well as eGFR?

Accepted Answer

Because albuminuria independently predicts progression and cardiovascular risk at any given eGFR. KDIGO classifies CKD by Cause, GFR category (G1–G5), AND albuminuria category (A1 <30, A2 30–300, A3 >300 mg/g by urine albumin-to-creatinine ratio), displayed as a color-coded risk heat map. Two patients with the same eGFR but different albuminuria can sit in very different risk zones, so a urine ACR should be checked alongside eGFR — staging on eGFR alone is incomplete.

Question 6

When should the cystatin C–based eGFR be used?

Accepted Answer

KDIGO 2024 recommends confirming a creatinine-based eGFR with a cystatin C–based estimate (eGFRcr-cys) when a highly accurate GFR matters for a decision — confirming a diagnosis or stage near a threshold, drug dosing, or transplant evaluation — and when serum creatinine is unreliable because of non-GFR factors, especially extremes of muscle mass (very high or very low muscle, amputation, malnutrition, frailty). Cystatin C is largely independent of muscle mass, so the combined equation is more accurate than creatinine alone in these settings.

Stage	eGFR	Description	Typical action
G1	≥ 90	Normal or high	CKD only if a damage marker (e.g. albuminuria) persists >3 months
G2	60 – 89	Mildly decreased	Not CKD on eGFR alone; check albuminuria, monitor
G3a	45 – 59	Mildly–moderately decreased	Confirm chronicity; manage CV risk, BP, albuminuria
G3b	30 – 44	Moderately–severely decreased	Monitor closely; refer to nephrology if progressing
G4	15 – 29	Severely decreased	Refer to nephrology; begin kidney-replacement planning
G5	< 15	Kidney failure	Dialysis / transplant evaluation

Category	ACR (mg/g)	Description
A1	< 30	Normal to mildly increased
A2	30 – 300	Moderately increased
A3	> 300	Severely increased

eGFR Calculator (CKD-EPI)

Input

About

Formula

Interpretation

GFR categories (G1–G5) and clinical action

Albuminuria categories (A1–A3)

References

FAQ

Related Calculators